{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:33:46Z","timestamp":1778877226434,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","cardiovascularpathology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Pathology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.carpath.2015.09.008","type":"journal-article","created":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T06:58:19Z","timestamp":1446533899000},"page":"127-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Fenofibrate unexpectedly induces cardiac hypertrophy in mice lacking MuRF1"],"prefix":"10.1016","volume":"25","author":[{"given":"Traci L.","family":"Parry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gopal","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan C.","family":"Schisler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4145-2607","authenticated-orcid":false,"given":"Luge","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan T.","family":"Quintana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Lockyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cam","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0769-5816","authenticated-orcid":false,"given":"Monte S.","family":"Willis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carpath.2015.09.008_bb0005","doi-asserted-by":"crossref","first-page":"E723","DOI":"10.1152\/ajpendo.00326.2013","article-title":"Muscle RING finger-1 attenuates IGF-I-dependent cardiomyocyte hypertrophy by inhibiting JNK signaling","volume":"306","author":"Wadosky","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.carpath.2015.09.008_bb0010","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1161\/01.RES.0000259559.48597.32","article-title":"Muscle ring finger 1, but not muscle ring finger 2, regulates cardiac hypertrophy in vivo","volume":"100","author":"Willis","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.carpath.2015.09.008_bb0015","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCRESAHA.109.194928","article-title":"Cardiac muscle ring finger-1 increases susceptibility to heart failure in vivo","volume":"105","author":"Willis","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.carpath.2015.09.008_bb0020","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/cvr\/cvp348","article-title":"Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanisms","volume":"85","author":"Mearini","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.carpath.2015.09.008_bb0025","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1083\/jcb.200901052","article-title":"During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation","volume":"185","author":"Cohen","year":"2009","journal-title":"J Cell Biol"},{"key":"10.1016\/j.carpath.2015.09.008_bb0030","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1172\/JCI32827","article-title":"Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3","volume":"117","author":"Fielitz","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.carpath.2015.09.008_bb0035","doi-asserted-by":"crossref","first-page":"18135","DOI":"10.1073\/pnas.0404341102","article-title":"Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I","volume":"101","author":"Kedar","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.carpath.2015.09.008_bb0040","doi-asserted-by":"crossref","first-page":"H997","DOI":"10.1152\/ajpheart.00660.2008","article-title":"Muscle ring finger 1 mediates cardiac atrophy in vivo","volume":"296","author":"Willis","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.carpath.2015.09.008_bb0045","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mce.2015.06.008","article-title":"The ubiquitin ligase MuRF1 regulates PPARalpha activity in the heart by enhancing nuclear export via monoubiquitination","volume":"413","author":"Rodriguez","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.carpath.2015.09.008_bb0050","first-page":"3930","article-title":"Nuclear receptors PPARbeta\/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart","volume":"117","author":"Burkart","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.carpath.2015.09.008_bb0055","doi-asserted-by":"crossref","first-page":"17035","DOI":"10.1073\/pnas.1302546110","article-title":"Essential role of stress hormone signaling in cardiomyocytes for the prevention of heart disease","volume":"110","author":"Oakley","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.carpath.2015.09.008_bb0060","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.carpath.2012.10.005","article-title":"BMPER regulates cardiomyocyte size and vessel density in vivo","volume":"22","author":"Willis","year":"2013","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.carpath.2015.09.008_bb0065","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm1327","article-title":"A crucial role of mitochondrial Hsp40 in preventing dilated cardiomyopathy","volume":"12","author":"Hayashi","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.carpath.2015.09.008_bb0070","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1073\/pnas.072083799","article-title":"Molecular phenotyping for analyzing subtle genetic effects in mice: application to an angiotensinogen gene titration","volume":"99","author":"Kim","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.carpath.2015.09.008_bb0075","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2144\/04373RT02","article-title":"Universal mouse reference RNA derived from neonatal mice","volume":"37","author":"He","year":"2004","journal-title":"Biotechniques"},{"key":"10.1016\/j.carpath.2015.09.008_bb0080","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.compbiolchem.2005.08.006","article-title":"Comments on selected fundamental aspects of microarray analysis","volume":"29","author":"Riva","year":"2005","journal-title":"Comput Biol Chem"},{"key":"10.1016\/j.carpath.2015.09.008_bb0085","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1046-2023(03)00155-5","article-title":"Normalization of cDNA microarray data","volume":"31","author":"Smyth","year":"2003","journal-title":"Methods"},{"key":"10.1016\/j.carpath.2015.09.008_bb0090","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng1201-365","article-title":"Minimum information about a microarray experiment (MIAME) \u2014 toward standards for microarray data","volume":"29","author":"Brazma","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.carpath.2015.09.008_bb0095","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1056\/NEJM199908123410707","article-title":"Drug treatment of lipid disorders","volume":"341","author":"Knopp","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carpath.2015.09.008_bb0100","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.2165\/11208090-000000000-00000","article-title":"Fenofibrate: a review of its use in dyslipidaemia","volume":"71","author":"McKeage","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.carpath.2015.09.008_bb0105","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1042\/bj3550481","article-title":"Differential involvement of peroxisome-proliferator-activated receptors alpha and delta in fibrate and fatty-acid-mediated inductions of the gene encoding liver fatty-acid-binding protein in the liver and the small intestine","volume":"355","author":"Poirier","year":"2001","journal-title":"Biochem J"},{"key":"10.1016\/j.carpath.2015.09.008_bb0110","doi-asserted-by":"crossref","first-page":"16710","DOI":"10.1074\/jbc.273.27.16710","article-title":"Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner","volume":"273","author":"Motojima","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.carpath.2015.09.008_bb0115","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1074\/jbc.273.10.5678","article-title":"Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha)","volume":"273","author":"Aoyama","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.carpath.2015.09.008_bb0120","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1093\/ndt\/gfr613","article-title":"High-fat diet-induced renal cell apoptosis and oxidative stress in spontaneously hypertensive rat are ameliorated by fenofibrate through the PPARalpha\u2013FoxO3a\u2013PGC-1alpha pathway","volume":"27","author":"Chung","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.carpath.2015.09.008_bb0125","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1161\/CIRCRESAHA.110.223818","article-title":"PGC-1 coactivators in cardiac development and disease","volume":"107","author":"Rowe","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.carpath.2015.09.008_bb0130","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jmb.2005.05.021","article-title":"MURF-1 and MURF-2 target a specific subset of myofibrillar proteins redundantly: towards understanding MURF-dependent muscle ubiquitination","volume":"350","author":"Witt","year":"2005","journal-title":"J Mol Biol"},{"key":"10.1016\/j.carpath.2015.09.008_bb0135","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10863-014-9549-9","article-title":"MuRF1 activity is present in cardiac mitochondria and regulates reactive oxygen species production in vivo","volume":"46","author":"Mattox","year":"2014","journal-title":"J Bioenerg Biomembr"},{"key":"10.1016\/j.carpath.2015.09.008_bb0140","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.mito.2006.09.001","article-title":"Wy-14,643 and fenofibrate inhibit mitochondrial respiration in isolated rat cardiac mitochondria","volume":"6","author":"Zungu","year":"2006","journal-title":"Mitochondrion"},{"key":"10.1016\/j.carpath.2015.09.008_bb0145","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1194\/jlr.M600364-JLR200","article-title":"Diabetes or peroxisome proliferator-activated receptor alpha agonist increases mitochondrial thioesterase I activity in heart","volume":"48","author":"King","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1016\/j.carpath.2015.09.008_bb0150","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1742-7843.2011.00748.x","article-title":"Effects of doxorubicin and fenofibrate on the activities of NADH oxidase and citrate synthase in mice","volume":"109","author":"Yao","year":"2011","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.carpath.2015.09.008_bb0155","doi-asserted-by":"crossref","first-page":"E967","DOI":"10.1152\/ajpendo.00165.2011","article-title":"Cardiac proteasome activity in muscle ring finger-1 null mice at rest and following synthetic glucocorticoid treatment","volume":"301","author":"Hwee","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.carpath.2015.09.008_bb0160","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1210\/jc.2005-1615","article-title":"Effects of short-term fenofibrate treatment on circulating markers of inflammation and hemostasis in patients with impaired glucose tolerance","volume":"91","author":"Okopien","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.carpath.2015.09.008_bb0165","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.atherosclerosis.2009.02.034","article-title":"Antithrombotic and antiplatelet activities of fenofibrate, a lipid-lowering drug","volume":"206","author":"Lee","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.carpath.2015.09.008_bb0170","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1152\/physiolgenomics.00100.2011","article-title":"Comparative transcriptomic and metabolomic analysis of fenofibrate and fish oil treatments in mice","volume":"43","author":"Lu","year":"2011","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.carpath.2015.09.008_bb0175","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.amjcard.2014.10.018","article-title":"Effects of niacin, statin, and fenofibrate on circulating proprotein convertase subtilisin\/kexin type 9 levels in patients with dyslipidemia","volume":"115","author":"Khera","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carpath.2015.09.008_bb0180","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.atherosclerosis.2011.02.012","article-title":"Comparison of effects of bezafibrate and fenofibrate on circulating proprotein convertase subtilisin\/kexin type 9 and adipocytokine levels in dyslipidemic subjects with impaired glucose tolerance or type 2 diabetes mellitus: results from a crossover study","volume":"217","author":"Noguchi","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.carpath.2015.09.008_bb0185","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1161\/CIRCRESAHA.112.270207","article-title":"Human molecular genetic and functional studies identify TRIM63, encoding Muscle RING Finger Protein 1, as a novel gene for human hypertrophic cardiomyopathy","volume":"111","author":"Chen","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.carpath.2015.09.008_bb0190","doi-asserted-by":"crossref","first-page":"9302","DOI":"10.3390\/ijms15069302","article-title":"Rare variants in genes encoding MuRF1 and MuRF2 are modifiers of hypertrophic cardiomyopathy","volume":"15","author":"Su","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.carpath.2015.09.008_bb0195","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1093\/hmg\/ddv311","article-title":"New cardiac and skeletal protein aggregate myopathy associated with combined MuRF1 and MuRF3 mutations","volume":"24","author":"Olive","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.carpath.2015.09.008_bb0200","doi-asserted-by":"crossref","first-page":"9160","DOI":"10.3390\/ijms15059160","article-title":"The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate suppresses chemically induced lung alveolar proliferative lesions in male obese hyperlipidemic mice","volume":"15","author":"Kuno","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.carpath.2015.09.008_bb0205","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1113\/jphysiol.2007.141507","article-title":"A functional insulin-like growth factor receptor is not necessary for load-induced skeletal muscle hypertrophy","volume":"586","author":"Spangenburg","year":"2008","journal-title":"J Physiol"},{"key":"10.1016\/j.carpath.2015.09.008_bb0210","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2174\/1874467211205020224","article-title":"The involvement of PPARs in the causes, consequences and mechanisms for correction of cardiac lipotoxicity and oxidative stress","volume":"5","author":"Sugden","year":"2012","journal-title":"Curr Mol Pharmacol"},{"key":"10.1016\/j.carpath.2015.09.008_bb0215","first-page":"149","article-title":"The selected pathophysiological aspects of PPARs activation","volume":"56","author":"Kiec-Wilk","year":"2005","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.carpath.2015.09.008_bb0220","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1440-1681.2010.05442.x","article-title":"Leptin induces hypertrophy through activating the peroxisome proliferator-activated receptor alpha pathway in cultured neonatal rat cardiomyocytes","volume":"37","author":"Hou","year":"2010","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.carpath.2015.09.008_bb0225","doi-asserted-by":"crossref","first-page":"H936","DOI":"10.1152\/ajpheart.00870.2007","article-title":"Overexpression of pyruvate dehydrogenase kinase 4 in heart perturbs metabolism and exacerbates calcineurin-induced cardiomyopathy","volume":"294","author":"Zhao","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.carpath.2015.09.008_bb0230","doi-asserted-by":"crossref","first-page":"11155","DOI":"10.1074\/jbc.M110.217349","article-title":"Chronic inhibition of pyruvate dehydrogenase in heart triggers an adaptive metabolic response","volume":"286","author":"Chambers","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.carpath.2015.09.008_bb0235","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.yjmcc.2014.12.001","article-title":"Mitochondrial remodeling in mice with cardiomyocyte-specific lipid overload","volume":"79","author":"Elezaby","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.carpath.2015.09.008_bb0240","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/cbf.2969","article-title":"Muscle ring finger 1 and muscle ring finger 2 are necessary but functionally redundant during developmental cardiac growth and regulate E2F1-mediated gene expression in vivo","volume":"32","author":"Willis","year":"2014","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.carpath.2015.09.008_bb0245","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0022-2275(20)31655-2","article-title":"Disturbances in the normal regulation of SREBP-sensitive genes in PPAR alpha-deficient mice","volume":"42","author":"Patel","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.carpath.2015.09.008_bb0250","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/CIRCRESAHA.108.186205","article-title":"The PPARalpha\/p16INK4a pathway inhibits vascular smooth muscle cell proliferation by repressing cell cycle-dependent telomerase activation","volume":"103","author":"Gizard","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.carpath.2015.09.008_bb0255","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1128\/MCB.00690-09","article-title":"A new role for sterol regulatory element binding protein 1 transcription factors in the regulation of muscle mass and muscle cell differentiation","volume":"30","author":"Lecomte","year":"2010","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.carpath.2015.09.008_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050878","article-title":"SREBP-1 transcription factors regulate skeletal muscle cell size by controlling protein synthesis through myogenic regulatory factors","volume":"7","author":"Dessalle","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.carpath.2015.09.008_bb0265","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1161\/CIRCRESAHA.109.193995","article-title":"Role of SREBP-1 in the development of parasympathetic dysfunction in the hearts of type 1 diabetic Akita mice","volume":"105","author":"Park","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.carpath.2015.09.008_bb0270","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1172\/JCI32011","article-title":"Parasympathetic response in chick myocytes and mouse heart is controlled by SREBP","volume":"118","author":"Park","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.carpath.2015.09.008_bb0275","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.phrs.2010.11.002","article-title":"Pleiotropic actions of fenofibrate on the heart","volume":"63","author":"Balakumar","year":"2011","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.carpath.2015.09.008_bb0280","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0002-9343(87)90865-5","article-title":"Structure and biochemical effects of fenofibrate","volume":"83","author":"Kloer","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.carpath.2015.09.008_bb0285","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1345\/aph.1C257","article-title":"Fenofibrate potentiates warfarin effects","volume":"37","author":"Kim","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.carpath.2015.09.008_bb0290","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.mce.2013.03.006","article-title":"Fenofibrate ameliorates cardiac hypertrophy by activation of peroxisome proliferator-activated receptor-alpha partly via preventing p65-NFkappaB binding to NFATc4","volume":"370","author":"Zou","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.carpath.2015.09.008_bb0295","first-page":"470","article-title":"PPAR alpha activator fenofibrate regressed left ventricular hypertrophy and increased myocardium PPAR alpha expression in spontaneously hypertensive rats","volume":"36","author":"Chen","year":"2007","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.carpath.2015.09.008_bb0300","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/HYPERTENSIONAHA.107.092403","article-title":"Effects of fenofibrate on cardiac remodeling in aldosterone-induced hypertension","volume":"50","author":"Lebrasseur","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.carpath.2015.09.008_bb0305","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1210\/en.2002-0217","article-title":"Peroxisome proliferator activated receptor (PPAR)alpha agonists inhibit hypertrophy of neonatal rat cardiac myocytes","volume":"144","author":"Liang","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.carpath.2015.09.008_bb0310","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.abb.2011.11.024","article-title":"PPARalpha activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4","volume":"518","author":"Le","year":"2012","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.carpath.2015.09.008_bb0315","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/cvr\/cvq401","article-title":"Suppression of endothelin-1-induced cardiac myocyte hypertrophy by PPAR agonists: role of diacylglycerol kinase zeta","volume":"90","author":"Huang","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.carpath.2015.09.008_bb0320","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1016\/j.febslet.2007.06.017","article-title":"Activation of peroxisome proliferator-activated receptor-alpha prevents glycogen synthase 3beta phosphorylation and inhibits cardiac hypertrophy","volume":"581","author":"Li","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1016\/j.carpath.2015.09.008_bb0325","doi-asserted-by":"crossref","first-page":"H1983","DOI":"10.1152\/ajpheart.00002.2009","article-title":"Fenofibrate inhibits aldosterone-induced apoptosis in adult rat ventricular myocytes via stress-activated kinase-dependent mechanisms","volume":"296","author":"De Silva","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.carpath.2015.09.008_bb0330","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1111\/j.1582-4934.2008.00484.x","article-title":"Effects and mechanisms of PPARalpha activator fenofibrate on myocardial remodelling in hypertension","volume":"13","author":"Li","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.carpath.2015.09.008_bb0335","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.CIR.0000112596.06954.00","article-title":"Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway","volume":"109","author":"Irukayama-Tomobe","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2015.09.008_bb0340","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/FJC.0b013e31822368d7","article-title":"Reactivation of peroxisome proliferator-activated receptor alpha in spontaneously hypertensive rat: age-associated paradoxical effect on the heart","volume":"58","author":"Purushothaman","year":"2011","journal-title":"J Cardiovasc Pharmacol"}],"container-title":["Cardiovascular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054880715001192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054880715001192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T01:54:00Z","timestamp":1653443640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054880715001192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1054880715001192"],"URL":"https:\/\/doi.org\/10.1016\/j.carpath.2015.09.008","relation":{},"ISSN":["1054-8807"],"issn-type":[{"value":"1054-8807","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fenofibrate unexpectedly induces cardiac hypertrophy in mice lacking MuRF1","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carpath.2015.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}